Xavier G. Thomas

Pierre Bénite Université Claude Bernard Lyon I Faculté De Médecine Lyon Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 238 publications

Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Journal: Cancers
Published: May 16, 2026

The continuing search for effective treatments for older adults with acute myeloid leukemia.

The continuing search for effective treatments for older adults with acute myeloid leukemia.

Journal: Expert review of clinical pharmacology
Published: November 26, 2025

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.

Journal: The oncologist
Published: September 23, 2025

Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid Leukemia.

Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid Leukemia.

Journal: Current oncology reports
Published: April 11, 2025

Examining the safety and efficacy of imetelstat in low-risk myelodysplastic syndrome.

Examining the safety and efficacy of imetelstat in low-risk myelodysplastic syndrome.

Journal: Expert opinion on pharmacotherapy
Published: February 24, 2025

Promising Drugs Targeting Specific Mechanisms of Deregulation in T Cell Lineage Acute Lymphoblastic Leukemia.

Promising Drugs Targeting Specific Mechanisms of Deregulation in T Cell Lineage Acute Lymphoblastic Leukemia.

Journal: Oncology and therapy
Published: November 07, 2024

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS.

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS.

Journal: Blood advances
Published: July 19, 2024

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Journal: Blood cancer journal
Published: April 03, 2024

Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?

Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?

Journal: Oncology and therapy
Published: January 05, 2024

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia.

Journal: Blood
Published: December 15, 2023

Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation.

Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation.

Journal: Oncology and therapy
Published: December 01, 2023

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.

Journal: Blood advances
Published: October 30, 2023
Showing 1-12 of 238

Last Updated: 09/26/2026